Department of Psychiatry, University of Colorado, Denver, CO, USA.
AIDS Behav. 2011 Jan;15(1):30-44. doi: 10.1007/s10461-010-9751-7.
This study of 632 drug injectors enrolled in eight residential detoxification centers within the National Drug Abuse Treatment Clinical Trials Network tested three interventions to reduce drug and sex risk behaviors. Participants were randomized to: (a) a two-session, HIV/HCV counseling and education (C&E) model added to treatment as usual (TAU), (b) a one-session, therapeutic alliance (TA) intervention conducted by outpatient counselors to facilitate treatment entry plus TAU, or (c) TAU. Significant reductions in drug and sex risk behaviors occurred for all three conditions over a 6-month follow-up period. C&E participants reported significantly greater rates of attending an HIV testing appointment, but this was not associated with better risk reduction outcomes. Reporting treatment participation within 2 months after detoxification and self-efficacy to practice safer injection behavior predicted reductions in injection risk behaviors. Findings indicate that participation in detoxification was followed by significant decreases in drug injection and risk behaviors for up to 6-months; interventions added to standard treatment offered no improvement in risk behavior outcomes.
本研究对 632 名在国家药物滥用治疗临床试验网络内的 8 个住院戒毒中心参加的药物注射者进行了研究,测试了三种减少药物和性风险行为的干预措施。参与者被随机分配到以下三组:(a)在常规治疗(TAU)基础上增加两阶段的 HIV/HCV 咨询和教育(C&E)模式,(b)由门诊顾问进行的单一阶段的治疗联盟(TA)干预,以促进治疗开始并增加 TAU,或(c)TAU。在 6 个月的随访期间,所有三组的药物和性风险行为都显著减少。C&E 组报告的接受 HIV 检测预约的比例显著更高,但这与降低风险的效果无关。报告在戒毒后 2 个月内接受治疗和实践更安全注射行为的自我效能预测注射风险行为的减少。研究结果表明,戒毒后最多 6 个月内药物注射和风险行为显著减少;标准治疗中增加的干预措施并没有改善风险行为的结果。
Drug Alcohol Depend. 2021-9-1
Subst Abuse Treat Prev Policy. 2019-1-3
Evid Based Med Public Health. 2016
Addiction. 2009-8-4
J Acquir Immune Defic Syndr. 2007-9-1
Drug Alcohol Depend. 2004-5-10
J Subst Abuse Treat. 2003-6
J Acquir Immune Defic Syndr. 2002-7-1
J Subst Abuse Treat. 2001-6